x

Search for a clinical trial

* (*) mandatory field

Non-Randomized, Open Label Phase II Safety/Efficacy Study: Replace Sandostatine® in Three Daily Subcutaneous Injections by a Single Intramuscular Injection of Sandostatine® LP Per Month in Patients With a Diffuse Form of Hyperinsulinism

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : Yes
  • Status : Terminated trial
  • Funding body(ies) :
  • Geographic coverage : National
  • Sponsor : Ap-hp (drcd)
  • Website
    • Phase : II
  • Principal investigator of clinical trial

  • Pr Pascale DE LONLAY
  • Service des Maladies Métaboliques pédiatriques
  • Hôpital Necker-Enfants Malades
  • 149 rue de Sèvres
  • 75743 PARIS
  • FRANCE
  • More information
  • Phone  : 33 (0)1 44 49 48 52 (enf)
  • Fax  : 33 (0)1 44 49 48 50
  • Website
  • Contact secretary  :
  • Sponsor of clinical trial

  • AP-HP (DRCD)
  • Délégation à la Recherche Clinique et à l'Innovation de l'AP-HP
  • Carré historique de l'hôpital Saint-Louis - Secteur gris - Porte 23
  • CHU Paris-GH St-Louis Lariboisière F.Widal - Hôpital Saint-Louis
  • 1 avenue Claude Vellefaux
  • 75010 PARIS
  • FRANCE
  • More information
  • Phone  : 33 (0)1 44 84 17 23
  • Fax  : 33 (0)1 44 84 17 99
  • Website
  • Contact secretary  :
Last update: November 2014

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.